DrugPatentWatch Database Preview
Portola Pharms Inc Company Profile
What is the competitive landscape for PORTOLA PHARMS INC, and when can generic versions of PORTOLA PHARMS INC drugs launch?
There are ten US patents protecting PORTOLA PHARMS INC drugs.
There are one hundred and eighteen patent family members on PORTOLA PHARMS INC drugs in thirty-one countries.
Summary for Portola Pharms Inc
| International Patents: | 118 |
| US Patents: | 10 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Portola Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | RX | Yes | No | 8,691,847 | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | RX | Yes | No | 6,376,515 | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | RX | Yes | Yes | 9,629,831 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | RX | Yes | No | 8,557,852 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for Portola Pharms Inc
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 6,844,367 | Benzamides and related inhibitors of factor Xa | ➤ Try a Free Trial |
| 9,061,019 | Pharmaceutical salts and polymorphs of a factor Xa inhibitor | ➤ Try a Free Trial |
| 7,314,874 | Benzamides and related inhibitors of factor Xa | ➤ Try a Free Trial |
| 7,342,013 | Benzamides and related inhibitors of factor Xa | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Portola Pharms Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 0164642 | ➤ Try a Free Trial |
| China | 101652136 | ➤ Try a Free Trial |
| Russian Federation | 2012104816 | ➤ Try a Free Trial |
| Japan | 2009514976 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
